Manufactured nanomaterials (MNM) have specific properties of great interest to industry. However, the health effects are not yet known for certain. GAIKER provides valuable support for the responsible development of this type of products. Our toxicological strategy for nanoparticles considers the final application, the route of entry into the body and the type of exposure (acute or chronic)
Safe products from the early stages of development: “Safe by Design”
Product safety evaluation
We carry out physical-chemical analysis (TEM, SEM, DLS, Z-potential) and in vitro toxicological evaluations.
Subscribe to our newsletter